Security key
90400D108
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)
CUSIP: 90400D108
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 67,540,585
- Total 13F value
- $4,030,154,883
- Share change
- +595,841
- Put/Call ratio
- 113%
- SEC-reported price per share
- $59.66
- Number of holders
- 210
- Value change
- +$24,063,212
- Number of buys
- 110
- Number of sells
- 110
- Shares outstanding
- 98,459,627
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
210
Top holders
10
RARE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Ultragenyx Pharmaceutical Inc. SEC filings
Ultragenyx Pharmaceutical Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 90400D108
Recent filing periods:
Ownership snapshot
Top reported holders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
12%
VANGUARD GROUP INC
6.1%
FEDERATED HERMES, INC.
4.1%
BlackRock Finance, Inc.
3.5%
WELLINGTON MANAGEMENT GROUP LLP
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
12%
|
$863,073,000
11,884,786 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
6.1%
|
$433,060,000
5,963,374 shares
|
— | 31 Mar 2022 |
| FEDERATED HERMES, INC. |
13F
Company
|
4.1%
|
$289,589,000
3,987,728 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
3.5%
|
$249,862,000
3,440,671 shares
|
— | 31 Mar 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
3.4%
|
$244,747,000
3,370,245 shares
|
— | 31 Mar 2022 |
| Capital International Investors |
13F
Company
|
3.4%
|
$242,891,000
3,345,026 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
210
Shares
67,540,585
Rows available
210
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
227
Q2 2022 holders
210
Holder diff
-17
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend